查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
数字计量吸入器市场规模、份额和趋势分析报告：按产品、适应症、类型、地区和细分市场预测，2023-2030 年
市场调查报告书
商品编码
1321361

数字计量吸入器市场规模、份额和趋势分析报告：按产品、适应症、类型、地区和细分市场预测，2023-2030 年

Digital Dose Inhaler Market Size, Share & Trends Analysis Report By Product (MDI, DPI), By Indication (Asthma, COPD), By Type (Branded Medication, Generic Medication), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 74 Pages | 商品交期: 2-10个工作天内

价格

数字计量吸入器市场增长和趋势

根据Grand View Research, Inc.最新报告，预计到2030年，全球数字计量吸入器市场规模将达到533.2亿美元，2023年至2030年年复合成长率为19.4%。

该市场利润丰厚的增长的关键因素包括老年人口的不断增加和慢性呼吸道疾病的激增。

中国、印度、巴西和菲律宾等新兴国家的经济发展带来了人均收入的增长，预计这将影响对技术先进的呼吸设备的需求。此外，儿科和老年患者可以使用利用这些技术的呼吸设备来提高患者的依从性和剂量跟踪，并增强患者与医疗保健提供者的联繫，从而实现医疗资料的实时跟踪。这些都是有影响力的渲染因素，并显着推动未来九年的市场增长。

为了满足目标人群未满足的需求，供应商正在扩大生产单位，并确保长期增长和盈利，他们将目标瞄准慢性肺病和气喘，例如亚太地区和未满足的需求。的因此，上述业务扩张趋势预计将在预测期内推动数字计量吸入器的使用。

此外，美国FDA 推动的固定剂量组合 (FDC) 的引入、仿製药的快速采用以及对数字健康平台的需求不断增长等有利的政府倡议将影响这些数字吸入器的快速采用。人口增长率的一个重要决定因素，预计这种情况在未来几年将持续下去。

世界人口迅速老龄化，睡眠呼吸中止呼吸暂停、气喘和慢性阻塞性肺病等各种慢性呼吸道疾病的患病率不断上升，对医疗保健系统产生了负面影响。这将进一步增加对创新呼吸设备的需求，并推动预测期内数字计量吸入器市场的增长。

数字计量吸入器市场报告亮点

  • 2015年，计量吸入器（MDI）领域的收入最大，为5.639亿美元。
  • 然而，由于人们越来越认识到在计量吸入器中用作推进剂的氯氟烃的不利影响，干粉吸入器 (DPI) 领域预计将成为增长最快的类别，在预测期内年复合成长率16.9%。此外，MDI 药物刺激的盛行以及人们对使用 DPI 相对于 MDI 的益处的认识不断增强，是预计在预测期内进一步促进 DPI 使用的关键因素。
  • 2015年，品牌製药呼吸设备类别占据最大市场份额，达7.476亿美元。
  • 2015年北美地区所占份额最大，超过38.64%。这一巨大份额归因于该地区多家医疗器械厂商的存在，包括强生公司、Cohera Medical, Inc、Teleflex Medical, Inc 和 Covidien Plc。该地区有6000多家医疗器械生产企业，其中大多数是中小企业。此外，老年人口的增长以及气喘和慢性阻塞性肺病等慢性呼吸道疾病患病率的激增是预计在预测期内积极加强数字计量吸入器市场的少数因素之一。
  • 亚太地区 (APAC) 预计在预测期内将以年复合成长率17.2% 的良好速度增长。医疗保健支出的快速增加以及美国FDA 在中国和印度等亚太国家的製造地的增加预计将对数字计量吸入器的市场渗透率产生重大影响。
  • 此外，人们对呼吸设备中采用的各种创新技术的认识不断提高，政府持续采取有利措施进一步鼓励使用仿製药，以及对医疗设备电子零件製造的各种补贴；以及多项税收优惠政策，使医疗设备出口能够顺利进行。预计该地区在预测期内将大力促进市场增长。
  • 市场领先的公司包括 Glenmark Pharmaceuticals Ltd.、Novartis AG、Propeller Health、AstraZeneca Plc、Philips Respironics、Opko Health, Inc. 和 Teva Pharmaceuticals Industries Ltd.。

目录

第1章调查方法与范围

  • 市场区隔和范围
  • 调查方法
  • 资讯采购
  • 资讯或资料分析
  • 市场形成和检验
  • 型号详情
  • 二手资讯清单
  • 主要资讯清单
  • 目的

第2章执行摘要

第3章数字计量吸入器市场变量、趋势、范围

  • 市场体系预测
    • 母公司市场预测
    • 相关/附市场预测
  • 采用和增长预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 数字计量吸入器市场分析工具
    • 行业分析-波特
    • PESTEL分析

第4章数字定量吸入器：产品估算和趋势分析

  • 数字计量吸入器市场：要点
  • 数字计量吸入器市场：2022 年和 2030 年趋势和市场份额分析
  • 定量吸入器 (MDI)
  • 干粉吸入器 (DPI)

第5章数字计量吸入器市场：类型估计和趋势分析

  • 数字计量吸入器市场：要点
  • 数字计量吸入器市场：2022 年和 2030 年趋势和市场份额分析
  • 品牌药品
  • 仿製药

第6章数字计量吸入器市场：适应症估计和趋势分析

  • 数字计量吸入器市场：要点
  • 数字计量吸入器市场：2022 年和 2030 年趋势和市场份额分析
  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 其他的

第7章数字计量吸入器市场：区域估计和趋势分析

  • 区域展望
  • 按地区分類的数字计量吸入器市场：主要市场要点
  • 北美
    • 2018-2030 年市场估计和预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 鲷鱼
    • 韩国
  • 拉美
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙特阿拉伯
    • 南非
    • 阿拉伯联合酋长国
    • 科威特

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • 3M Company
    • AstraZeneca Plc
    • Glenmark Pharmaceuticals Ltd.
    • Novartis AG
    • Propeller Health
    • Sensirion AG Switzerland
    • Opko Health, Inc.
    • Teva Pharmaceuticals Industries Ltd
    • BEXIMCO Pharmaceuticals
    • GlaxoSmithKline Plc
    • Mundipharma Deutschland GmbH & Co. KG
Product Code: 978-1-68038-953-1

Digital Dose Inhaler Market Growth & Trends

The global digital dose inhaler market size is expected to reach USD 53.32 billion by 2030, registering a CAGR of 19.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors contributing to the lucrative growth of this market include the continually increasing elderly population and the surging prevalence of chronic respiratory diseases.

As a result of impactful economic developments in the fast emerging countries, such as China, India, Brazil, Philippines, and others, there has been growth in the per capita income, which is thus expected to influence the demand for the technologically advanced respiratory devices. Moreover, these technology-enabled respiratory devices are greatly sought after among the pediatric and the geriatric population so as to improve the patient medication compliance, dose tracking, and to enhance patient-healthcare practitioner connectivity that would enable real-time tracking of healthcare data; these serve as high impact rendering factors, significantly driving the market growth in the next nine years.

In order to cater to the unmet needs of the target population, the vendors are expanding their production units and in addition, targeting the niche areas where the prevalence of chronic lung diseases and asthma are on the rise, such as Asia Pacific and MEA regions, to ensure long-term growth and profitability. Therefore, the aforementioned, business expansion trends are expected to boost the usage rates of the digital dose inhalers over the forecast period.

Additionally, favorable government initiatives, such as the introduction of Fixed Dose Combination (FDC), advanced by the U.S. FDA, fast increasing adoption of generic drugs, and the growing demand for digital health platforms are the identified crucial determinants influencing the rapid uptake of these digital inhalers, which is expected to continue in the coming years.

Rapidly increasing geriatric population worldwide in conjunction with the growing prevalence of various chronic respiratory conditions, such as chronic sleep apnea, asthma, COPD, among others negatively impact healthcare system. This would further escalate the demand for innovative respiratory devices thereby encouraging the digital dose inhalers market growth during the forecast period.

Digital Dose Inhaler Market Report Highlights

  • In 2015, the metered dose inhalers (MDIs) segment accounted for the maximum revenue of USD 563.9 million, mainly on account of the increased preference for MDIs.
  • However, the dry powder inhalers (DPIs) segment is expected to emerge as the fastest growing category with a CAGR of 16.9% over the forecast period owing to the growing awareness regarding the adverse effects of chlorofluorocarbons employed as a propellant in the MDIs. Moreover, widespread incidences of drug irritation due to MDI and rising awareness regarding the benefits of using DPIs over MDIs are the leading factors expected to further drive the usage rates of DPIs over the forecast period.
  • In 2015, the branded medication respiratory devices category accounted for the largest market share of USD 747.6 million attributable to the steadily growing need for advanced respiratory drugs and the awareness related to the benefits of combination medication gaining prominence.
  • North America held the maximum share of over 38.64% in 2015. This large share is attributed to the presence of several medical device players in this region, such as Johnson & Johnson, Cohera Medical, Inc., Teleflex Medical, Inc., Covidien Plc, and others. There are over 6,000 medical device companies domiciled in this region, which majorly consists of small and medium sized enterprises (SMEs). Moreover, the soaring geriatric population count and the surging prevalence of chronic respiratory diseases, such as asthma and COPD, are few factors, among others, expected to positively reinforce the digital dose inhaler market over the forecast period.
  • The Asia Pacific (APAC) region is anticipated to grow at a lucrative pace with a CAGR of 17.2% over the forecast period. The upsurge in the healthcare expenditure and the increasing number of U.S. FDA manufacturing sites in APAC countries, such as in China and India, are expected tosignificantly impact the market penetration of the digital dose inhalers.
  • Furthermore, the growing awareness regarding the various innovative technologies employed in the respiratory devices, the ongoing favorable government initiatives that further encourage the use of generic drugs, various subsidies for electronic component manufacturing of medical devices, and several tax benefits that enable medical device exports from this region are anticipated to strongly reinforce the market growth over the forecast period.
  • Some leading players of the market include Glenmark Pharmaceuticals Ltd., Novartis AG, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Inc., and Teva Pharmaceuticals Industries Ltd.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Type
    • 1.1.3. Indication
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Indication outlook
    • 2.2.3. Type outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Dose Inhaler Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Digital Dose Inhaler Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Digital Dose Inhaler: Product Estimates & Trend Analysis

  • 4.1. Digital Dose Inhaler Market: Key Takeaways
  • 4.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Metered Dose Inhaler (MDI)
    • 4.3.1. Metered Dose Inhaler (MDI) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Dry powder Inhaler (DPI)
    • 4.4.1. Dry Powder Inhaler (DPI) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Digital Dose Inhaler Market: Type Estimates & Trend Analysis

  • 5.1. Digital Dose Inhaler Market: Key Takeaways
  • 5.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Branded Medication
    • 5.3.1. Branded medication market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Generic Medication
    • 5.4.1. Generic medication market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Digital Dose Inhaler Market: Indication Estimates & Trend Analysis

  • 6.1. Digital Dose Inhaler Market: Key Takeaways
  • 6.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Asthma
    • 6.3.1. Asthma market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Chronic Obstructive Pulmonary Disease (COPD)
    • 6.4.1. Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Digital Dose Inhaler Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Digital Dose Inhaler Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. 3M Company
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. AstraZeneca Plc
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Glenmark Pharmaceuticals Ltd.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Novartis AG
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Propeller Health
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Sensirion AG Switzerland
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Opko Health, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Teva Pharmaceuticals Industries Ltd
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. BEXIMCO Pharmaceuticals
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. GlaxoSmithKline Plc
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Mundipharma Deutschland GmbH & Co. KG
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 5 North America digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 9 Canada digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 12 Europe digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Europe digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 19 UK digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 22 France digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 23 France digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 24 France digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 25 Italy digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Spain digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 30 Spain digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 31 Sweden digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 33 Sweden digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Norway digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 36 Norway digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Denmark digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 44 China digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 45 China digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 46 China digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Japan digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 50 India digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 51 India digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 52 India digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Thailand digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 55 Thailand digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 56 South Korea digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 59 Latin America digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 61 Latin America digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Latin America digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 64 Brazil digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 65 Brazil digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 66 Mexico digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 67 Mexico digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 68 Mexico digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 69 Argentina digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 70 Argentina digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 71 Argentina digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Africa digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Africa digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 79 UAE digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 80 UAE digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 81 UAE digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Kuwait digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 83 Kuwait digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 84 Kuwait digital dose inhaler market, by indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Digital dose inhaler: Market outlook
  • Fig. 9 Digital dose inhaler competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Digital dose inhaler market driver impact
  • Fig. 15 Digital dose inhaler market restraint impact
  • Fig. 16 Digital dose inhaler market strategic initiatives analysis
  • Fig. 17 Digital dose inhaler market: Product movement analysis
  • Fig. 18 Digital dose inhaler market: Product outlook and key takeaways
  • Fig. 19 Metered Dose Inhaler (MDI) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Dry Powder Inhaler (DPI) market estimates and forecasts, (USD million), 2018 - 2030
  • Fig. 21 Digital dose inhaler market: Type movement analysis
  • Fig. 22 Digital dose inhaler market: Type outlook and key takeaways
  • Fig. 23 Branded medication market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Generic medication market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Digital dose inhaler market: Indication movement analysis
  • Fig. 26 Digital dose inhaler market: Indication outlook and key takeaways
  • Fig. 27 Asthma market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global digital dose inhaler market: Regional movement analysis
  • Fig. 31 Global digital dose inhaler market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)